Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Cellectar patents

Patents where

Current Assignee

Name

Cellectar

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11467159 Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells		Cellectar	Cellectar	United States Patent and Trademark Office	11467159	October 11, 2022
‌ US Patent 9480754 Phospholipid ether analogs as cancer-targeting drug vehicles	Patent 9480754 was granted and assigned to Cellectar on November, 2016 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9480754	November 1, 2016
‌ US Patent 9345718 Phospholipid ether analogs as cancer-targeting drug vehicles	Patent 9345718 was granted and assigned to Cellectar on May, 2016 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9345718	May 24, 2016
‌ US Patent 9616140 Fluorescent phospholipid ether compounds, compositions, and methods of use	Patent 9616140 was granted and assigned to Cellectar on April, 2017 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9616140	April 11, 2017
‌ US Patent 11439709 Phospholipid ether analogs as cancer-targeting drug vehicles		Cellectar	Cellectar	United States Patent and Trademark Office	11439709	September 13, 2022
‌ US Patent 9925269 Phospholipid ether analogs as cancer-targeting drug vehicles	Patent 9925269 was granted and assigned to Cellectar on March, 2018 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9925269	March 27, 2018
‌ US Patent 9339564 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer	Patent 9339564 was granted and assigned to Cellectar on May, 2016 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9339564	May 17, 2016
‌ US Patent 7811548 Fluorescent phospholipid ether compounds and compositions	Patent 7811548 was granted and assigned to Cellectar on October, 2010 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	7811548	October 12, 2010
‌ US Patent 9550002 Phospholipid analogs as diapeutic agents and methods thereof	Patent 9550002 was granted and assigned to Cellectar on January, 2017 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9550002	January 24, 2017
‌ US Patent 7893286 Method for the synthesis of phospholipid ethers	Patent 7893286 was granted and assigned to Cellectar on February, 2011 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	7893286	February 22, 2011
‌ US Patent 8877160 Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof	Patent 8877160 was granted and assigned to Cellectar on November, 2014 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	8877160	November 4, 2014
‌ US Patent 8877159 Phospholipid analogs as diapeutic agents and methods thereof	Patent 8877159 was granted and assigned to Cellectar on November, 2014 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	8877159	November 4, 2014
‌ US Patent 9579406 Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof	Patent 9579406 was granted and assigned to Cellectar on February, 2017 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	9579406	February 28, 2017
‌ US Patent 7632644 Imaging and selective retention of phospholipid ether analogs	Patent 7632644 was granted and assigned to Cellectar on December, 2009 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	7632644	December 15, 2009
‌ US Patent 7700075 Virtual colonoscopy with radiolabeled phospholipid ether analogs	Patent 7700075 was granted and assigned to Cellectar on April, 2010 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	7700075	April 20, 2010
‌ US Patent 8871181 Fluorescent phospholipid ether compounds, compositions, and methods of use	Patent 8871181 was granted and assigned to Cellectar on October, 2014 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	8871181	October 28, 2014
‌ US Patent 8535641 Phospholipid analogs as diapeutic* agents and methods thereof	Patent 8535641 was granted and assigned to Cellectar on September, 2013 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	8535641	September 17, 2013
‌ US Patent 10004818 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer	Patent 10004818 was granted and assigned to Cellectar on June, 2018 by the United States Patent and Trademark Office.	Cellectar	Cellectar	United States Patent and Trademark Office	10004818	June 26, 2018
‌ US Patent 8022235 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use	Patent 8022235 was granted and assigned to Cellectar on September, 2011 by the United States Patent and Trademark Office.		Cellectar	United States Patent and Trademark Office	8022235	September 20, 2011
‌ US Patent 8540968 Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof			Cellectar	United States Patent and Trademark Office	8540968	September 24, 2013

20 results

0 selected

20 results

0 selected